1. Home
  2. THRD vs LASR Comparison

THRD vs LASR Comparison

Compare THRD & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • LASR
  • Stock Information
  • Founded
  • THRD 2019
  • LASR 2000
  • Country
  • THRD United States
  • LASR United States
  • Employees
  • THRD N/A
  • LASR N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • LASR Semiconductors
  • Sector
  • THRD Health Care
  • LASR Technology
  • Exchange
  • THRD Nasdaq
  • LASR Nasdaq
  • Market Cap
  • THRD 512.9M
  • LASR 530.3M
  • IPO Year
  • THRD 2022
  • LASR 2018
  • Fundamental
  • Price
  • THRD $13.93
  • LASR $14.68
  • Analyst Decision
  • THRD Strong Buy
  • LASR Strong Buy
  • Analyst Count
  • THRD 3
  • LASR 3
  • Target Price
  • THRD $20.33
  • LASR $15.83
  • AVG Volume (30 Days)
  • THRD 184.1K
  • LASR 343.1K
  • Earning Date
  • THRD 11-07-2024
  • LASR 11-07-2024
  • Dividend Yield
  • THRD N/A
  • LASR N/A
  • EPS Growth
  • THRD N/A
  • LASR N/A
  • EPS
  • THRD N/A
  • LASR N/A
  • Revenue
  • THRD N/A
  • LASR $197,564,000.00
  • Revenue This Year
  • THRD N/A
  • LASR $2.22
  • Revenue Next Year
  • THRD N/A
  • LASR $19.87
  • P/E Ratio
  • THRD N/A
  • LASR N/A
  • Revenue Growth
  • THRD N/A
  • LASR N/A
  • 52 Week Low
  • THRD $5.82
  • LASR $9.52
  • 52 Week High
  • THRD $16.94
  • LASR $15.00
  • Technical
  • Relative Strength Index (RSI)
  • THRD 54.76
  • LASR 74.08
  • Support Level
  • THRD $11.69
  • LASR $12.13
  • Resistance Level
  • THRD $14.64
  • LASR $13.56
  • Average True Range (ATR)
  • THRD 0.99
  • LASR 0.66
  • MACD
  • THRD -0.04
  • LASR 0.28
  • Stochastic Oscillator
  • THRD 67.67
  • LASR 98.98

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About LASR nLIGHT Inc.

nLight Inc is a United States-based company engaged in providing semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. It designs, develops and manufactures the critical elements of lasers, through its vertically integrated business model to rapidly introduce innovative products, control costs and protect intellectual property. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, China, and the Rest of the world.

Share on Social Networks: